Found 5 matching trials
Efficacy of PD-1 Inhibitor Combination Therapy in Non-small Cell Lung Cancer Patients Who Have Not Achieved Major Pathologic Response After Neoadjuvant Immunotherapy: a Multicenter, Phase II Clinical Trial PHASE2 Exploring the efficacy of PD-1 inhibitor combination therapy strategies for...
Show More Location
Shanghai Pulmonary Hospital
Learn More & Join Trial
Polarized Dendritic Cell (aDC1) Based Treatment, Interferon Alpha-2, Rintatolimod, and Celecoxib for the Treatment of HLA-A2+ Refractory Melanoma PHASE2 This phase II trial studies how well polarized dendritic cell (aDC1) based ...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer EARLY_PHASE1 This pilot trial studies how well chemokine modulation therapy works when g...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
ฮฑDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies PHASE1 This trial is to determine the safest dose of a triple combination (chemoki...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial
Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer PHASE1 This phase I trial studies how well chemokine modulation therapy and standa...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial